Ikorni Invest Oy

Ikorni Invest Oy Ab is a Finnish family office established in 2012, dedicated to supporting long-lasting impact through its investments. The firm primarily focuses on impact-driven ventures across three core areas: sustainable development, life sciences, and agriculture & foodtech. They seek out solutions that harmonise growth with responsibility, advancing technologies and business models that conserve natural resources, promote clean energy, and foster resilient communities. In life sciences, they back innovations that enhance quality of life, ranging from cutting-edge therapeutics and diagnostics to digital health solutions. Within agriculture & foodtech, Ikorni Invest supports pioneers who are transforming the global food system by driving efficiency, sustainability, and nutrition through science, technology, and smarter agricultural practices.

Founded in 2012, Ikorni Invest began its journey by investing in startups across diverse industries. Over time, the firm refined its strategy to concentrate on impact-driven ventures, becoming a founder-friendly investor. Their mission is to empower entrepreneurs who integrate robust technology with a clear purpose, focusing on solutions that deliver both economic and environmental benefits. The firm values practical innovation, measurable environmental and social impact, and a long-term perspective over fleeting trends.

Since its inception, Ikorni Invest has built a substantial portfolio, having made over 50 direct investments in unlisted companies and acquiring stakes in several venture capital and private equity funds. Notable portfolio companies include Carbonaide, which is revolutionising the concrete industry through carbon dioxide curing and permanent CO₂ storage. Another key investment is Elea & Lili, a company developing cellulose-based superabsorbent materials as a sustainable, fossil-free alternative to traditional polymers for products like diapers and agricultural applications. The portfolio also features Askel Healthcare, which develops advanced regenerative solutions for cartilage repair, and CeLLife, a deep technology company specialising in diagnostics and quality control for the battery industry.

The firm's leadership includes Johan Niklas Erik Geust, who serves as the Managing Director. The team at Ikorni Invest is committed to identifying and nurturing entrepreneurial talent that aligns with their vision of creating a positive and lasting impact. They leverage their expertise to support companies that are not only technologically sound but also deeply committed to addressing critical global challenges.